Abstract:Background: Tripterygium wilfordii Hook F provided the source of the first diterpenoid triepoxide lactone, Triptolide, identified as the primary constituent causing the anticancer activity. So far, it has not been reported whether triptolide has a therapeutic effect on cutaneous squamous cell carcinoma (cSCC). Objective: This study investigates the triptolide's therapeutic impact on cSCC both in vitro and in vivo and investigates the triptolide's potential involvement in signaling pathways. Methods: The CCK-8 assays, wound healing assays, and colony formation assays were used to assess the effects of triptolide on the proliferation and migration of cSCC cells. The alteration in gene expression following triptolide treatment was shown by RNA sequencing. Flow cytometry was then applied to evaluate cell apoptosis. Western blot was used to find the associated proteins' expressions. The effectiveness of triptolide was then evaluated in vivo using a xenograft model, and histological staining was employed to determine the visceral toxicity. Results: Triptolide greatly reduces the migratory and proliferative capacity of cSCC cells. Triptolide dramatically decreased cell viability and migration in the A431 and SCL-1 cells compared to the control group, according to the CCK8 assay, wound healing assay, and colony formation assay. Flow cytometry demonstrated that treatment with 10-40 nM triptolide increased apoptosis in a concentration-dependent manner, with a statistically significant difference. Furthermore, mice given triptolide had smaller tumor sizes than those in the control group. Triptolide treatment drastically altered the expression of autophagic and apoptotic proteins. The considerable reduction in the proteins Akt and mTOR levels further illustrated the critical function of triptolide in cSCC. Conclusion: Triptolide caused cSCC cells to engage in autophagy and apoptosis by inhibiting the Akt/mTOR signaling pathways. Triptolide may be a possible antitumor agent for the treatment of cSCC.

Triptolide Inhibits Proliferation and Induces Apoptosis of Human Melanoma A375 Cells.

Triptolide Down-regulates Bcr-abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

Triptolide Induces S Phase Arrest Via the Inhibition of Cyclin E and CDC25A and Triggers Apoptosis Via Caspase- and Mitochondrial-Dependent Signaling Pathways in A375.S2 Human Melanoma Cells

Triptolide Inhibits Transcription Factor Nf-Kappab and Induces Apoptosis of Multiple Myeloma Cells

Inhibition of Hsp90 by Triptolide (tpl) Augments Bortezomib-Induced U266 Cells Apoptosis

Triptolide suppresses melanoma cell growth in vitro and in vivo through the Src-ERK signaling pathway

Triptolide Inhibits the Proliferation of Cells from Lymphocytic Leukemic Cell Lines in Association with Downregulation of NF-κB Activity and Mir-16-1*.

Triptolide Induces Apoptosis of Human Pancreatic Cancer Cells

Triptolide Induced DNA Damage in A375.S2 Human Malignant Melanoma Cells is Mediated Via Reduction of DNA Repair Genes.

Effect of Triptolide on the Proliferation and Apoptosis of Human Epidermal Squamous Cell Carcinoma Cell Line A431 in Vitro

Triptolide Induces Apoptosis in Human Adrenal Cancer Nci-H295 Cells Through A Mitochondrial-Dependent Pathway

[Effect of Triptolide on Human Oral Cancer Cell Proliferation and PTEN Gene Mrna Expression in Oral Cancer].

Effect of triptolide on proliferation and apoptosis,cycloxygenase-2 and survivin mRNA expression in squamous carcinoma cell line A431

Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells

Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells.

Triptolide-induced Apoptosis by Inactivating Nuclear Factor-Kappa B Apoptotic Pathway in Multiple Myeloma in Vitro

P25 Trichodimerol induces apoptosis in A375-S2 human melanoma cells through modulation of ERK and p38 activities mediated by reactive oxygen species

Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway

Triptolide Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma <i>via</i> Akt/mTOR Pathway

Effects of Matrine on the Proliferation and Apoptosis Induction in Human Malignant Melanoma Cell Line A375

Triptolide Induces Growth Inhibition And Apoptosis Of Human Laryngocarcinoma Cells By Enhancing P53 Activities And Suppressing E6-Mediated P53 Degradation